Dimensional Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $581M | Buy |
1,168,956
+179,614
| +18% | +$79.6M | 0.11% | 149 |
|
|
2026
Q1 | $442M | Buy |
989,342
+43,682
| +5% | +$20.4M | 0.09% | 196 |
|
|
2025
Q4 | $429M | Buy |
945,660
+162,074
| +21% | +$69.9M | 0.09% | 192 |
|
|
2025
Q3 | $307M | Buy |
783,586
+187,359
| +31% | +$78.3M | 0.07% | 314 |
|
|
2025
Q2 | $265M | Sell |
596,227
-9,652
| -2% | -$4.45M | 0.06% | 355 |
|
|
2025
Q1 | $294M | Sell |
605,879
-21,638
| -3% | -$10.1M | 0.07% | 274 |
|
|
2024
Q4 | $253M | Sell |
627,517
-20,291
| -3% | -$9.41M | 0.06% | 359 |
|
|
2024
Q3 | $301M | Sell |
647,808
-15,149
| -2% | -$7.28M | 0.07% | 285 |
|
|
2024
Q2 | $311M | Buy |
662,957
+75,045
| +13% | +$32.6M | 0.08% | 223 |
|
|
2024
Q1 | $246M | Buy |
587,912
+2,696
| +0.5% | +$1.14M | 0.07% | 325 |
|
|
2023
Q4 | $238M | Sell |
585,216
-7,179
| -1% | -$2.65M | 0.07% | 306 |
|
|
2023
Q3 | $206M | Sell |
592,395
-18,304
| -3% | -$6.4M | 0.07% | 312 |
|
|
2023
Q2 | $215M | Sell |
610,699
-10,116
| -2% | -$3.41M | 0.07% | 306 |
|
|
2023
Q1 | $196M | Sell |
620,815
-159,687
| -20% | -$47.9M | 0.07% | 326 |
|
|
2022
Q4 | $225K | Sell |
780,502
-83,805
| -10% | -$25.5M | 0.07% | 273 |
|
|
2022
Q3 | $250M | Sell |
864,307
-17,338
| -2% | -$4.99M | 0.1% | 200 |
|
|
2022
Q2 | $248M | Sell |
881,645
-71,529
| -8% | -$19.1M | 0.09% | 213 |
|
|
2022
Q1 | $249M | Buy |
953,174
+19,141
| +2% | +$4.54M | 0.08% | 279 |
|
|
2021
Q4 | $205M | Buy |
934,033
+229,487
| +33% | +$44.6M | 0.06% | 361 |
|
|
2021
Q3 | $128M | Buy |
704,546
+185,523
| +36% | +$36.2M | 0.04% | 635 |
|
|
2021
Q2 | $105M | Buy |
519,023
+49,412
| +11% | +$10.3M | 0.03% | 814 |
|
|
2021
Q1 | $101M | Buy |
469,611
+15,062
| +3% | +$3.31M | 0.03% | 823 |
|
|
2020
Q4 | $107M | Buy |
454,549
+18,974
| +4% | +$4.35M | 0.04% | 685 |
|
|
2020
Q3 | $119M | Buy |
435,575
+3,625
| +0.8% | +$1M | 0.05% | 456 |
|
|
2020
Q2 | $125M | Buy |
431,950
+35,100
| +9% | +$9.52M | 0.06% | 400 |
|
|
2020
Q1 | $94.4M | Buy |
396,850
+22,425
| +6% | +$5.14M | 0.05% | 462 |
|
|
2019
Q4 | $82M | Buy |
374,425
+1,852
| +0.5% | +$375K | 0.03% | 904 |
|
|
2019
Q3 | $63.1M | Buy |
372,573
+1,056
| +0.3% | +$187K | 0.02% | 1150 |
|
|
2019
Q2 | $68.1M | Buy |
371,517
+6,005
| +2% | +$1.05M | 0.03% | 1081 |
|
|
2019
Q1 | $67.2M | Buy |
365,512
+40,427
| +12% | +$7.47M | 0.03% | 1066 |
|
|
2018
Q4 | $53.9M | Buy |
325,085
+11,848
| +4% | +$2.05M | 0.02% | 1151 |
|
|
2018
Q3 | $60.4M | Sell |
313,237
-8,109
| -3% | -$1.44M | 0.02% | 1242 |
|
|
2018
Q2 | $54.6M | Buy |
321,346
+200
| +0.1% | +$31K | 0.02% | 1321 |
|
|
2018
Q1 | $52.3M | Buy |
321,146
+8,640
| +3% | +$1.41M | 0.02% | 1292 |
|
|
2017
Q4 | $46.8M | Buy |
312,506
+15,625
| +5% | +$2.31M | 0.02% | 1420 |
|
|
2017
Q3 | $45.1M | Buy |
296,881
+14,066
| +5% | +$2.12M | 0.02% | 1405 |
|
|
2017
Q2 | $36.4M | Buy |
282,815
+9,882
| +4% | +$1.19M | 0.02% | 1572 |
|
|
2017
Q1 | $29.8M | Buy |
272,933
+5,496
| +2% | +$484K | 0.01% | 1704 |
|
|
2016
Q4 | $19.7M | Buy |
267,437
+8,524
| +3% | +$694K | 0.01% | 1990 |
|
|
2016
Q3 | $22.6M | Buy |
258,913
+9,896
| +4% | +$935K | 0.01% | 1823 |
|
|
2016
Q2 | $21.4M | Buy |
249,017
+810
| +0.3% | +$70K | 0.01% | 1776 |
|
|
2016
Q1 | $19.7M | Buy |
248,207
+8,583
| +4% | +$776K | 0.01% | 1823 |
|
|
2015
Q4 | $30.2M | Buy |
239,624
+14,019
| +6% | +$1.69M | 0.02% | 1388 |
|
|
2015
Q3 | $23.5M | Sell |
225,605
-113
| -0.1% | -$14.5K | 0.02% | 1577 |
|
|
2015
Q2 | $27.9M | Sell |
225,718
-5,656
| -2% | -$713K | 0.02% | 1503 |
|
|
2015
Q1 | $27.3M | Buy |
231,374
+1,117
| +0.5% | +$134K | 0.02% | 1474 |
|
|
2014
Q4 | $27.4M | Buy |
230,257
+2,319
| +1% | +$261K | 0.02% | 1405 |
|
|
2014
Q3 | $25.6M | Buy |
227,938
+2,163
| +1% | +$206K | 0.02% | 1356 |
|
|
2014
Q2 | $21.4M | Sell |
225,775
-523
| -0.2% | -$36.7K | 0.01% | 1596 |
|
|
2014
Q1 | $16M | Buy |
226,298
+2,655
| +1% | +$210K | 0.01% | 1795 |
|
|
2013
Q4 | $16.6M | Buy |
223,643
+16,274
| +8% | +$1.13M | 0.01% | 1724 |
|
|
2013
Q3 | $15.7M | Buy |
207,369
+60,681
| +41% | +$4.83M | 0.01% | 1696 |
|
|
2013
Q2 | $11.7M | Buy |
+146,688
| New | +$10.8M | 0.01% | 1869 |
|
Other funds holding VRTX
Dimensional Fund Advisors's VRTX Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 18% in Q2 2026, buying an estimated $79.6M and bringing the position to 1,168,956 shares worth $581M. The position accounts for 0.11% of the portfolio, ranked #149.
Dimensional Fund Advisors first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Dimensional Fund Advisors held 1,168,956 shares of Vertex Pharmaceuticals worth $581M as of Q2 2026.
- Dimensional Fund Advisors bought 179,614 Vertex Pharmaceuticals shares in Q2 2026, an estimated $79.6M.
- Vertex Pharmaceuticals made up 0.11% of Dimensional Fund Advisors's portfolio in Q2 2026, its #149 holding.
- Dimensional Fund Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.